On the stock market since 2021, it operates in the everyday-essentials business. It has 91 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Growth: Sales growth trails the sector average.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
An investor who bought at the very peak is down 90% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $161.3M a year. A small number, but proof the product has real buyers.
There is $25.4M in the vault; even if every debt were paid off, $24.7M would remain.
It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.
A loss of $10.1M against $161.3M in annual sales.
The growth engine is running at low revs right now. Report-card grade: 23/100.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 24/100.
On our five-subject report card, ZVIA sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ZVIA is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Analysts’ average target sits above today’s price, yet the valuation grade (24/100) says the stock isn’t cheap.